ArticleBMC palliative care2024

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol.

David A Palma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.